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Exposure to altitude is commonly incorpo-rated into many athletes’ training pro-
grames. The rationale for such an inclusion is
that the reduction in inspired oxygen (O2) will
aggravate hematological, hormonal, metabolic,
and structural adjustments, facilitating im-
provements in O2 delivery and extraction that
may lead to improvements in sea-level exercise
performance. Erythropoietin (EPO) is largely
produced by the cells of the kidney and is re-
sponsible for the regulation of red blood cell
production (see review: Wang and Semenza,
1996). The drop in tissue partial pressure of O2
(PO2), resulting from both environmental hy-
poxia and altitude, has the ability to encourage
EPO release (see reviews: Wilber, 2001; Levine,
2002). Despite the depth of research support-
ing hypoxic-induced increases in EPO, there is
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ABSTRACT
MacKenzie, Richard W. A., Peter W. Watt, and Neil S. Maxwell. Acute normobaric hypoxia stim-
ulates erythropoietin release. High Alt. Med. Biol. 9:28–37, 2008.—Investigations studying the se-
cretion of EPO (erythropoietin) in response to acute hypoxia have produced mixed results. Fur-
ther, the errors associated with the various methods used to determine EPO are not well
documented. The purpose of the current study was to determine the EPO response of 17 trained
male subjects to either an acute bout of normobaric hypoxia (Hy; n  10) or normoxia (Con; n 
7). A secondary aim was to determine the error associated with the measurement of EPO. After
baseline tests, the treatment group (Hy) underwent a single bout of hypoxic exposure (FIO2 
0.148; 3100 m) consisting of a 90-min rest period followed by a 30-min exercise phase (50%V˙O2max).
Venous blood samples were drawn pre (0 min) and post (120 min) each test to assess changes
in plasma EPO (EPO). The control (Con) group was subjected to the same general experimen-
tal design, but placed in a normoxic environment (FIO2  0.2093). The Hy group demonstrated
a mean increase in EPO [19.3 (4.4) vs. 24.1 (5.1) mU/mL], p  0.04, post 120 min of normobaric
hypoxia. The calculated technical error of measurement for EPO was 2.1 mU/mL (9.8%). It was
concluded that an acute bout of hypoxia, has the capacity to elevate plasma EPO. This study
also demonstrates that the increase in EPO accumulation was 2 times greater than the calculated
measurement of error.
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still evidence contradicting such findings
(Table 1).
To understand the inconsistency in these
findings, it seems necessary to consider that hy-
poxic-induced increases in EPO are ultimately
governed by upstream physiological charac-
teristics involved in the delivery of O2 to renal
tissue (Ge et al., 2002) and the transcriptional
factors associated to the O2-sensitive hypoxic-
inducible factor-1 (HIF-1) (Jedlickova et al.,
2003). However, a dose–response relationship
seems to exist between the magnitude of EPO
release and the degree of hypoxia, which com-
prise of two factors that are relatively simple to
manipulate [i.e., intensity (FIO2) and duration
of exposure].
Ge et al. (2002) concluded that an optimal
threshold for hypoxic-induced increases in
EPO lies at altitudes of 2100 to 2500 m (equiv-
alent to FIO2  0.169 to 0.157, respectively). This
is in agreement with previous work. The sum-
mary of data provided in Table 1 shows clearly
that when the FIO2 is equivalent to 0.14 to
0.16, EPO concentrations are significantly in-
creased. Indeed, only one of the studies ana-
lyzed in Table 1, which used a hypoxic stress
within the suggested threshold, offered no EPO
response (Karlsen et al., 2002).
Erythropoietin concentrations have been re-
peatedly shown to increase as a result of 70
to 120 min of acute and continuous hypoxic ex-
posure (Eckardt et al., 1989; Rodriguez et al.,
2000). Knaupp et al. (1992) demonstrated that
at least 120 min of continuous hypoxia (FIO2 
0.105) is required to augment kidney-induced
EPO production. Further, earlier work advo-
cated that continuous exposure to both 3000 m
for 114 min and 4000 m for 84 min results in
elevated EPO concentrations from 16.0 to 22.5
and 16.7 to 28.0 mU/mL, respectively (Ab-
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TABLE 1. SUMMARY OF STUDIES MEASURING ERYTHROPOIETIN RESPONSE TO HYPOXIA
Positive EPO response No EPO change
Altitude (actual and simulated)
2000 m (FIO2 0.167) Dehnert et al. (2002)
2000 m (FIO2 0.167) Eckardt et al. (1989); Laitinen et al. Karlsen et al. (2002)
(1995); Rusko et al. (1995); Mattila
and Rusko, (1996); Chapman et al. (1998);
Piehl-Aulin et al. (1998);
Rusko et al. (1999); Ashenden et al. (2000);
Koistinen et al. (2000); Stray-
Gundersen et al. (2001); Ge et al.
(2002); Friedmann et al. (2005)
3800 m (FIO2 0.135) Eckardt et al. (1989); Knaupp et al. Vallier et al. (1996); Garcia et
(1992); Savourey et al. (1996); al. (2000); Katayama et al.
Rodriguez et al. (2000); Niess et al. (2003); Julian et al. (2004);
(2004) Lundby et al. (2005)
Duration (h/day)
2 Knaupp et al. (1992); Rodriguez et Garcia et al. (2000); Karlsen et
al. (2000); Niess et al. (2004) al. (2002); Katayama et al.
(2003); Julian et al. (2004);
Lundby et al. (2005)
2 Knaupp et al. (1992); Friedmann N/A
et al. (2005)
5 Eckardt et al. (1989); Laitinen et al. N/A
(1995); Rusko et al. (1995); Mattila
and Rusko (1996); Savourey et al. (1996);
Chapman et al. (1998); Piehl-Aulin
et al. (1998a); Piehl-Aulin et al.
(1998b); Rusko et al. (1999);
Ashenden et al. (2000); Koistinen et
al. (2000); Stray-Gundersen et al.
(2001); Dehnert et al. (2002); Ge et
al. (2002)
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brecht and Littell, 1972; Eckardt et al., 1989).
However, most studies have used exposure
times greater than 2 h (Table 1).
The recent study by Julian et al. (2004) sug-
gested that 70 min of 5:5-min hypoxia (FIO2 
0.10 to 0.12) to normoxia ratio initiated no ery-
thropoietic response. The authors hypothe-
sized that the timings of blood collection could
have prevented the detection of possible
changes in EPO (Katayama et al., 2003, Julian
et al., 2004) and that a hypoxic–normoxic ratio
of 5:5 is an insufficient stress. Garcia et al. (2000)
failed to witness any change in EPO following
an exposure (FIO2  0.13; 3500 m) above what
Ge et al. (2002) termed the optimal threshold,
and the period of exposure was continuous
(120 min). The authors suggested, however,
that erythropoiesis may have indeed taken
place, because reticulocyte count increased sig-
nificantly after day 5 of continuous intermittent
hypoxia.
The majority of investigations examining the
effects of acute or intermittent hypoxia on EPO
response have used either rest or exercise pro-
tocols. Consequently, few studies have com-
bined inactive hypoxic exposure with a period
of exercise. Recently, Vogt and colleagues
(2001) demonstrated that mRNAs coding for
hypoxic-inducible factor-1 (HIF-1), a major
hypoxic transcriptional activator, are signifi-
cantly increased when exercise is combined
with hypoxia. This may suggest that HIF-1
stabilization is greater or even additive when
environmental hypoxia is combined with meta-
bolic stress, such as exercise (Vogt et al., 2001).
Three key factors could be used to explain
some of the lack in hypoxic-induced EPO in-
creases during acute (single) or intermittent (re-
peated) exposure: (1) inadequate hypoxic stim-
ulus in both FIO2 and time of exposures, (2)
limitations in study designs, such as timing of
blood collection, and (3) maybe associated with
the error in EPO measurement. Indeed, only 8
of the 23 studies summarized in Table 1 pro-
vided data for coefficient variations or techni-
cal error of measurement.
Thus, the purpose of the current study was
to determine plasma EPO response and its as-
sociated error in measurement to a total of 120
min of normobaric hypoxic (FIO2  0.148; 3100
m) exposure (rest phase, 90 min, and exercise
phase, 30 min, at 50% V˙O2max). We hypothe-
sized that this duration and intensity of hy-
poxia (i.e., FIO2), combined with moderate-in-




Seventeen physically trained males were re-
cruited for this study, which was approved by
the University of Brighton ethics committee.
Subjects gave their informed consent prior to
be being accepted to take part. Subjects were
healthy nonsmokers with no history of respi-
ratory diseases. Volunteers were also free from
any hematological infections or renal diseases.
Individuals were also excluded if they had vis-
ited altitudes above 1600 m or traveled by com-
mercial aircraft in the 8 weeks leading up to
data collection (Niess et al., 2004). Table 2
shows means (SD) physical characteristics for
both groups.
Study design
The experimental designed was based on
two laboratory visits. The first visit was used
to familiarize subjects and collect preliminary
data, and the second acted as the main test pro-
MACKENZIE ET AL.
TABLE 2. SUBJECT CHARACTERISTICS
Age, Ht Body mass Body fat V˙O2max Hb
(yr) (cm) (kg) (%) (mL/min/kg1) (g/dL)
Control group 23.3 (2.9) 181.0 (2.6) 74.6 (1.6) 10.1 (1.9) 60.8 (8.3) 15.5 (1.2)
(n  7)
Hypoxic group 24.0 (3.4) 178.2 (5.2) 76.0 (5.1) 11.7 (2.5) 57.4 (4.9) 15.2 (1.3)
(n  7)
Values are mean (SD).
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tocol. The first test visit provided values of the
subject’s lactate threshold and maximal oxygen
consumption (V˙O2max). Lactate threshold (LT)
tests began with a treadmill speed of 9 km/h1
and consisted of 5 to 8 submaximal stages that
increased by 1 km/h1 every 3 min. Oxygen
uptake was measured throughout using an on-
line system (Oxycon Pro, Jaeger, Germany)
shown to be both a valid and reliable means of
measuring online respiratory parameters
(Carter et al., 2002). The V˙O2max protocol was
adapted from Costill et al. (1969). Post the LT
phase, treadmill velocity was set at intensities
relative to individuals, using the velocity that
matched 150 (8) beats/min1 of heart rate ob-
tained during the LT phase. Treadmill gradient
started at 1% and increased by 1% every minute
until the end of the test.
Main protocol
On arrival to the laboratory, subjects pro-
vided a urine sample from which hydration
status was determined (Micro Osmometer;
Vitech 3300, Massachusetts, USA). If subject’s
hydration values exceeded 400 mOsmol/kg
H2O (Maresh et al., 2004) they were required
to consume 500 mL of water and wait 30 min
before being retested. Body mass, subject’s
height, and the percentage of body fat, using
the four-site method (bicep, triceps, sub-
scapula, and suprailiac), as described by
Durnin and Womersley (1974), were then
recorded. The main test protocol required the
subjects to return to the laboratory to sit at rest
(90 min) prior to performing treadmill exercise
(30 min) set at 50% relative V˙O2max in either a
normobaric hypoxic environment (Hy; FIO2 
0148; 3100 m; n  10) or in normoxia (Con;
FIO2  0.2093; n  7). To minimize the effects
of variations in circadian rhythms (Reilly et al.,
1984), all tests were carried out between 16:00
and 17:30 h.
Hemoglobin [Hb] (10 L) and resting blood
[La] (20–30 l) samples were also taken before
each condition (Hy and Con). [Hb] was mea-
sured from whole blood using a HemoCue de-
vice (HemoCue limited, Sheffield, UK). A mean
value was recorded from 2 or 3 samples. If there
was a difference of more than 3 g/dL between
the first two samples, the test was repeated
(Rechner et al., 2002). A separate fingertip
puncture (warmed to ensure arterialized
blood) was used to measure whole blood [La]
(YSI 2300 STAT Plus lactate analyzer, Yellow
Springs Instrument, Ohio, USA).
Normobaric hypoxia (Hy; FIO2  0.148) was
generated using a modified Colorado Altitude
Training Tent (Colorado Altitude Training,
Louisville, USA). Temperature, humidity, car-
bon dioxide, and barometric pressure were
monitored throughout. Minute ventilation (V˙E),
O2 uptake (V˙O2) and carbon dioxide production
(V˙CO2), respiratory exchange ratio (RER), heart
rate (HR), oxyhemoglobin saturation (SpO2;
pulse oximeter Nonin 2500, Minneapolis, Min-
nesota, USA), and rate of perceived exertion
(RPE) were recorded every 15 min during rest
and every 5 min during the exercise phase of
each condition (Con and Hy). Expired air was
collected using the Douglas bag technique.
During each Hy exposure, whole-blood [La]
samples were taken from a fingertip puncture
(capillary) site every 15 min during rest and 5
min during exercise. Arterial O2 content (CaO2)
was indirectly estimated using the equation de-
scribed by Ge et al. (2002), [CaO2  Hb
(g/dL) 	 SpO2 (%) 	 1.36 (mL/O2/dL
1)]. The
equation assumes a hemoglobin–O2 constant of
1.36 mL/O2/dL1. Erythropoietin concentra-
tions were measured in plasma, drawn from
whole blood samples taken pre (normoxic 
environment; 0 min1) and post (120 min1) 
for both groups (Con and Hy). Concentrations 
were determined using an enzyme-linked im-
munosorbent assay kit (Roche Diagnostics Ltd.,
Lewes, UK). The within and between coefficient
variations were 6.2% and 9.9%, respectively.
Statistics
Changes in plasma EPO concentrations were
analyzed using dependent t-tests with statisti-
cal significance set at p  0.05. Values are pre-
sented as means and standard deviation (SD)
with Pearson product correlation coefficients
calculated and shown where appropriate.
Bland and Altman (1986) 95% limits of agree-
ment (LOA) were calculated to show differ-
ences between duplicate EPO samples. Typical
error of measurement (TEM) calculations were
carried out on duplicate EPO samples using a
ACUTE NORMOBARIC HYPOXIA STIMULATES ERYTHROPOIETIN RELEASE
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method previously described by Hopkins
(2000). Briefly, the mean and SD of the differ-
ences between duplicate EPO samples were de-
termined and the value then divided by 2
and back-transformed to obtain a coefficient
variation (CV) (Gore and Hopkins, 2005). The
resultant TEM between duplicate samples was
9.8%, with a unit error value of 2.1 mmole/mL.
Statistics software SPSS (version 12.0) was used
to analyze all data.
RESULTS
Mean (SD) arterial oxygen content (CaO2)
values are shown in Fig. 1. The hypoxic proto-
col utilized was found to be effective, as dem-
onstrated by significantly lower values in the
Hy condition when compared to the Con group
during both the rest phase [Con, 20.3 (1.6); Hy,
19.8 (1.5) mL/O2/dL1], p  0.003, and the ex-
ercise phase [Con 19.2 (1.4); Hy, 18.0 (1.8)
mL/O2/dL1], p  0.003.
Changes in plasma EPO (EPO) concentra-
tions for pre and post experimental trials are
shown in Fig. 2 for both the Con and Hy group.
The Hy group demonstrated a mean increase
from 19.3 (4.4) to 24.1 (5.1) mU/mL post 120
min1 of hypoxic exposure (p  0.04), with a
range from 5.6% to 61.8%. No significant dif-
ference was observed for the Con group [18.0
(2.1) vs. 19.1 (1.8) mU/mL] (Fig. 2.).
The degree of desaturation in SpO2 from
baseline (FIO2  0.2093) to the point of hypoxic
exposure was noted to be significant in the Hy
group [normoxia: 98 (1); hypoxia: 91 (3)], p 
0.001. Correlation coefficients were calculated
for EPO against SpO2 and CaO2. The de-
gree of SpO2 desaturation correlated moder-
ately with EPO (r  0.54), p  0.017). Delta
changes in EPO and CaO2 generated a similar
correlation coefficient of r  0.54 (P  0.026)
(Fig. 3.).
The level of agreement calculated for the dif-
ferences between duplicate EPO samples was
5.45 and 6.01 mmol/mL, with a mean differ-
ence of 0.28 (2.9), p  0.001. Figure 4 shows that
4.7% of the data points fell outside of 95% lim-
its of agreement. Technical error of measure-
ment calculation for differences between the
same duplicate samples offered an error value
of 2.1 mmol/mL. Correlation coefficient for du-























FIG. 1. Arterial O2 content (CaO2) for Con (open circles) and Hy group (black circles). Values are mean (SD). Sta-
tistical difference was noted between Hy and Con for both rest (p  0.003) and exercise (p  0.003).
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DISCUSSION
The aim of the current investigation was to
measure the response of plasma EPO to nor-
mobaric hypoxia. The hypoxic protocol utilized
in the current study was concluded as an ef-
fective stress with exercise further exaggerat-
ing hypoxemia (Fig. 1.) (Garcia et al., 2000).
Thus the salient observation was that an acute
bout (120 min) of hypoxia (FIO2  0.148) com-
bined with the metabolic stress of exercise sta-
tistically increased plasma EPO levels and that
this increase was 2 times greater (4.8 mmol/
mL) than the error associated with our mea-
surement (2.1 mmole/mL).
Hypoxic-induced elevations in EPO and so
possible increased erythropoiesis has clear tan-
gible benefits for both athletic (Stray-Gunder-
sen et al., 2001) and clinical (Silverberg et al.,
2004; Corwin, 2004) populations. However,
other investigations have failed to conclude the
effectiveness of acute on intermittent hypoxia
(Vallier et al., 1996; Karlsen et al., 2002;
Katayama et al., 2003; Julian et al., 2004). For a
review, see Wilber (2001). Further, investiga-
tions that have demonstrated EPO increases
(Eckardt et al., 1989; Knaupp et al., 1992;
Ashenden et al., 2000; Rodriguez et al., 2000;
Ge et al., 2002) have failed to publish data on
their error of measurement.
It is possible that the error in EPO measure-
ment or reliability of this measure could pre-
vent some investigations from detecting a true
effect (Hopkins, 2000). As the current study
aimed to measure the change in EPO, the
within subjects and between tests (pre vs. post)
variations were of critical importance. It is es-
sential to point out that there was a magnitude
of variation in the light absorbance detected
during EPO measurement (TEM  2.1 mmol/






































FIG. 3. Relationship between the degrees of change in EPO (EPO) is correlated with the magnitude of desatura-
tion in CaO2 (p  0.026).
FIG. 2. Mean (SD) EPO response for baseline (closed
bars) and postexperimental trial (open bars) for both con-
trol (Con) and hypoxic (Hy) groups. *Level of significance
(p  0.04)
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mL). This within-test variation was not de-
tected through the more traditional methods of
identifying differences, demonstrated by a cor-
relation coefficient of r  0.94, which suggests
a high level of agreement, and is further high-
lighted by the limits of agreement plot (LOA;
Fig. 4.). This plot is proposed to offer more va-
lidity when comparing two different samples
measuring the same substance. Essentially, the
plot suggests that 95% confidence can be as-
sumed when using the mean value for each du-
plicated sample (Bland and Altman, 1986).
However, the calculated bias (5.45 
 6.01)
and LOA plot are considerable and therefore
do not highlight differences that are technically
important. More precisely, the LOA are ap-
proximately 3 times the size of the error of mea-
surement (Hopkins, 2000).
However, it was concluded that there was a
true effect in individual EPO response within
the current study. Recently, Lundby and col-
leagues (2005) concluded that 120 min of hy-
pobaric hypoxia was not great enough to cause
a significant increase in EPO; yet their data pro-
duced a mean increase of 31.6%. It is at least
plausible that the lack of a statistical change in
EPO in the Lundby et al. (2005) study and other
work (Katayama et al., 2003) may have been
due to error of measurement (TEM). However,
this is at best speculative, as the authors did not
publish these data. In fact, only 8 out of the 23
studies summarized in Table 1 provided val-
ues for coefficient variations (CV) or TEMs.
Klausen’s work has shown that circulating
EPO concentrations are subject to a distinct di-
urnal variation in both normoxia and hypoxia
(Klausen et al., 1996). The present study con-
trolled for differences in diurnal variation of
EPO by ensuring that subjects were tested
within a 1.5 h period. Further, it is entirely pos-
sible that discrepancies between investigations
could also be attributed to differences in the as-
says kits used (Clanton and Klawitter, 2001).
Hypoxic-induced changes in EPO release
seem to be subject to a marked interindividual
variability (Chapman et al., 1998), which may
further explain some of the inconsistencies in
the literature. It is clear from the data in the
current study that EPO release is subject to a
distinct difference in the level of response, with
values ranging from 5.6% to 61.8% (mean,
21%). The production of EPO is noticeably
augmented by the depression of CaO2, result-
ing from decreases in oxyhemoglobin satura-
tion (SpO2), (Eckardt et al., 1993; Maxwell et al.,


























FIG. 4. Plot of differences between duplicate EPO samples using limits of agreement (Bland and Altman, 1986).
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bined with an inability to increase HVR could
facilitate a greater secretion of EPO (Jelkmann,
1992), which could, in part, explain some of the
individual EPO variation. However, the mag-
nitude of oxyhemoglobin desaturation (SpO2)
and reduction in CaO2 correlated only moder-
ately with changes in EPO (r  0.54 and r 
0.54, respectively), which agrees almost iden-
tically with the data of Ge et al. (2002) and sug-
gests that SpO2 and CaO2 during hypoxic ex-
posure can only partly explain the differences
in EPO secretion (Cohen, 1988).
Finally, the use of recurrent episodes of hy-
poxia, which are indicative of the live-high,
train-low (LHTL) method of hypoxia training,
have produced mixed results on both hemato-
logical adjustments and sea-level exercise per-
formance variables. Recently, Gore et al. (2005)
suggested that intermittent hypoxic exposure
did not stimulate erythropoiesis despite eleva-
tions in serum EPO. In contrast, Basset et al.
(2006) clearly demonstrated that short-term hy-
poxia increased levels of EPO, Hb, hematocrit,
and red blood cells without offering an ex-
pected sea-level exercise performance. These
authors proposed that differences in individual
adaptive responses to intermittent hypoxia
may affect exercise performance and that in-
sensitive physiological measurers may prevent
the detection of possible changes in exercise
performance.
In conclusion, it is clear from the findings of
the present study that EPO release is moder-
ately increased as a result of 120 min of acute
normobaric hypoxic (rest = 90 min; exercise
[50%V˙O2max]  30 min), equivalent to 3100 m.
Further, the change in EPO accumulation can
be described as a true effect because the in-
crease was greater than the TEM. The increases
noted in the current investigation indicate that
the intensity (i.e., FIO2  0.148), duration (120
min) and type of exposure (rest combine with
an exercise phase) may have the ability to stim-
ulate erythropoiesis, if the exposure is part of
a continued programe of hypoxic treatments,
that is, the live-high, train-low method of alti-
tude training (Levine and Stray-Gunderson,
2005). However, this EPO release seems to be
subject to a distinct interindividual variation
that can only partly be explained by a reduc-
tion in oxyhemoglobin saturation and maybe
affected to a larger extent by factors related to
the stabilization of HIF-1.
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